US Patent Issued to Elanco US on March 24 for "IL17A antibodies and antagonists for veterinary use" (California Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,917, issued on March 24, was assigned to Elanco US Inc. (Greenfield, Ind.).

"IL17A antibodies and antagonists for veterinary use" was invented by Shyr Jiann Li (Millbrae, Calif.), Lam Nguyen (Union City, Calif.), Lan Yang (Union City, Calif.) and Hangjun Zhan (Foster City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are various embodiments relating to anti-IL17A antibodies and IL17Ra ECD polypeptides that bind to IL17A. In various embodiments, such anti-IL17A antibodies or IL17Ra ECD polypeptides can be used in methods to treat IL17-induced conditions in subjects, such as humans or companion animals, such as canines, felines, and...